Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 26 - Issue 8 - August 2014

Insights

Commentary
Atherectomy for Calcified Femoropopliteal Disease: Are We Making Progress?
08/05/2014

Dmitriy N. Feldman, MD

Dmitriy N. Feldman, MD
Femoropopliteal (FP) atherosclerotic disease is responsible for the majority of cases of symptomatic lower-extremity peripheral artery disease (PAD). Dr Feldman offers a thoughtful commentary on the results of the COMPLIANCE 360° Trial and...
Femoropopliteal (FP) atherosclerotic disease is responsible for the majority of cases of symptomatic lower-extremity peripheral artery disease (PAD). Dr Feldman offers a thoughtful commentary on the results of the COMPLIANCE 360° Trial and...
Femoropopliteal (FP)...
08/05/2014
Journal of Invasive Cardiology

Feature

Vascular Disease
Crossing of Infrainguinal Peripheral Arterial Chronic Total Occlusion With a Blunt Microdissection Catheter
08/05/2014

Subhash Banerjee, MD1,2;  Rahul Thomas, MD1;  Karan Sarode, MA1,2;  Atif Mohammad, MD1,2;  Salil Sethi, MD3; Mirza S. Baig, MD1,2;  Osvaldo S. Gigliotti, MD4;  M. Ishti Ali, MD5;  Andrew Klein, MD6;  Mazen S. Abu-Fadel, MD7;  Nicolas W. Shammas, MD8;  Anand Prasad, MD3;  Emmanouil S. Brilakis, MD, PhD1,2

Subhash Banerjee, MD1,2;  Rahul Thoma...
Crossing of lower-extremity arterial chronic total occlusion (CTO) can be challenging. This study examines the use of the Viance peripheral CTO crossing device (Covidien) in the superficial femoral, popliteal, and below-the knee arterial...
Crossing of lower-extremity arterial chronic total occlusion (CTO) can be challenging. This study examines the use of the Viance peripheral CTO crossing device (Covidien) in the superficial femoral, popliteal, and below-the knee arterial...
Crossing of lower-extremity...
08/05/2014
Journal of Invasive Cardiology
Original Contribution
Long-Term Comparative Analysis From an All-Comer Cohort of Coronary Patients Treated Using First- and Second-Generation Drug-Eluting Stents
08/05/2014

Pablo Codner, MD;  Tamir Bental, MD;  Abid Assali, MD;  Hana Vaknin-Assa, MD;  Eli Lev, MD;  Ran Kornowski, MD

Pablo Codner, MD;  Tamir Bental, MD; ...
Second-generation drug-eluting stent (DES) implantation gradually replaced the first-generation DES in clinical practice. This study explored the differences of clinical outcomes among DESs.
Second-generation drug-eluting stent (DES) implantation gradually replaced the first-generation DES in clinical practice. This study explored the differences of clinical outcomes among DESs.
Second-generation drug-eluting...
08/05/2014
Journal of Invasive Cardiology
Vascular Disease
The COMPLIANCE 360° Trial: A Randomized, Prospective, Multicenter, Pilot Study Comparing Acute and Long-Term Results of Orbital Atherectomy to Balloon Angioplasty for Calcified Femoropopliteal Disease
08/05/2014

Raymond Dattilo, MD1*;  Stevan I. Himmelstein, MD2;  Robert F. Cuff, MD, RVT3

Raymond Dattilo, MD1*;  Stevan I. Him...
This study compares treatment results of orbital atherectomy vs balloon angioplasty for calcified femoropopliteal disease. 12-month follow-up results are discussed.
This study compares treatment results of orbital atherectomy vs balloon angioplasty for calcified femoropopliteal disease. 12-month follow-up results are discussed.
This study compares treatment...
08/05/2014
Journal of Invasive Cardiology
Original Contribution
Preliminary Experience in the Use of CERA Occluders for Closure of Different Intracardiac and Extracardiac Shunts
08/04/2014

Roland Fiszer, MD1;  Malgorzata Szkutnik, MD2;  Beata Chodor, MD1;  Jacek Bialkowski, MD2

Roland Fiszer, MD1;  Malgorzata Szkut...
We present our preliminary experience in transcatheter closure of atrial septal defect, patent foramen ovale, patent ductus arteriosus, and postinfarction ventricular septal defect with the Cera occluder from Lifetech Scientific. 
We present our preliminary experience in transcatheter closure of atrial septal defect, patent foramen ovale, patent ductus arteriosus, and postinfarction ventricular septal defect with the Cera occluder from Lifetech Scientific. 
We present our preliminary...
08/04/2014
Journal of Invasive Cardiology

Column

Radial Access Technique
Predictors and Outcomes Associated With Radial Versus Femoral Access for Intervention in Patients With Acute Coronary Syndrome in a Real-World Setting: Results From the Acute Coronary Syndrome Israeli Survey (ACSIS) 2010
08/05/2014

Paul Fefer, MD1;  Shlomi Matetzky, MD1;  Sharon Gannot, MD1;  Shmuel Gottlieb, MD2;  David Meerkin, MD2;  Liudmila Bubyr, MD1;  Natalie Gavrielov, MD1;  Doron Zahger, MD3;  Ilan Goldenberg, MD1;  Ran Kornowski, MD4;  Amit Segev, MD1

Paul Fefer, MD1;  Shlomi Matetzky, MD...
Use of transradial intervention is becoming more popular, and recent studies suggest an advantage for TRI in high-risk patients presenting with acute coronary syndrome. This study describes current utilization and outcomes of transradial...
Use of transradial intervention is becoming more popular, and recent studies suggest an advantage for TRI in high-risk patients presenting with acute coronary syndrome. This study describes current utilization and outcomes of transradial...
Use of transradial intervention...
08/05/2014
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death  Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

August 2014 Volume 26 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement